NAC Eye Drops
N-ACETYL-CARNOSINE (NAC) EYE DROPS.
What are NAC Eye drops?
2 x 5ml vials per box containing 1% N-acetyl-carnosine.
NAC Eye Drops are formulated at ph 6.8 close to the normal ph of the eye.
Made in and shipped from the USA.
Why are you selling NAC eye drops instead of the drops with the brand name Can-C?
We have taken the desicion to support Amercian industry and commerce. NAC eye drops are made in the USA under strict controls. Can-C is manufactured outside of the USA and the worldwide distributor in Great Britain is often out of stock. CENTRAL chooses not to work with unreliable or untrustworthy suppliers.
Is NAC "approved"?
In the same way that Can-C is approved NAC is approved. Can-C is approved by the company behind the Can-C eye drop and the creators of the NAC eyedrop stand behind thier product and approve it as well. As with all vitamins and nutritional supplements, it doesn't need FDA approval.
The only reason IVP (the Russian company behind the Can-C eye drops) "approve" Can-C is because they are IVP's brand of the drops! There are many brand names out there, Nu-Eyes, Brite Eyes or our NAC eye drops. They all contain the all-important N-acetyl-carnosine (NAC) which is the 'ingredient' used in the clinical studies.
FREE and fast trackable shipping as standard on all orders over $149. USA ONLY.
The most commonly performed operation in the world is for senile cataracts. In the US alone there are nearly 1.5 million eye operations yearly and although recognised as being a safe operation, perhaps surprisingly, there are a significant amount of complications which, in some cases after the removal of a cataract will mean further lazer treatment within just two years. N-acetylcarnosine or NAC eye-drops can provide treatment without the need for surgery and will therefore allow the patient to keep their own lens rather than an artificial one.
Cataracts are caused in part by free radicals that create oxidative stress, which leads to the cross linking of lens proteins and ultimately worsening vision due to the amount of light reaching the retina. As we age the level of antioxidants in the eye diminishes leaving our eyes less protected against life in the 21st century - ultraviolet light, toxins, chemicals, pollution, computer screens etc. There are high levels of the antioxidant carnosine in the healthy human eye and low levels in those suffering with ocular diseases such as cataracts.
N-acetylcarnosine (NAC) is the most effective and specific form of carnosine for ocular health. When delivered to the eye it is an active bio-identical antioxidant. The first trials were with Russian patients who instilled 2 drops of 1% N-acetylcarnosine - NAC eye drops into each eye several times a day for a period of 6 months. For the treatment and reversal of eye disorders including certain senile cataracts, the positive effective rate was 100%.
In recent years a special analogue of the di-peptide carnosine N-acetylcarnosine (NAC) has undergone considerable research, particularly with its effect on the treatment and prevention of senile cataracts.
Worldwide, 42% of cases for the cause of blindness is due to cataract, affecting an estimated 17 million people with approximately 28,000 new cases are reported daily. With these statistics it is clear to understand why surgery on cataracts is the most commonly performed surgical procedure for the over 65's. Within this age group approximately 25% of the world's population has a loss of vision due to cataract. With the prospect that in the next 15 years 20% of population will be in this age group, the amount of people suffering with cataract will be staggering. As things stand now, in the US alone there are nearly 1.5 million cataract operations per year, so what will the future hold in response to this major disease?
Although cataract surgery is seen as being one of the safest operations, there is a significant rate in complications and in particular after an extraction, opacification of the posterior lens capsule occurs which requires further laser treatment. In the US this affects nearly 50% of patients. An even lesser known fact is that in the US out of the 1.5 million operations each year, nearly 30,000 individuals develop serious complications after the surgery. Besides these possible complications, an artificial lens does not have the same optical qualities or accommodation as a natural lens.
NAC eye drops present a major leap forward for possible prevention and treatment of senile cataract and a plausible alternative to surgery. Positive results are usually found after 3 months of continual daily usage and these include an improvement in night vision especially with glare sensitivity, more clarity of colors and an overall feeling of better eye health. Success rate for patients with senile cataract is commonly between 9-12 months of continual daily usage.
In a clinical trial of patients with senile cataract to varying degrees of maturity, NAC eye drops were used at a rate of 1 or 2 drops into each eye 3 or 4 times a day, for a period of 3 to 6 months. 100% of the patients with primary senile cataract experienced improvement and for those with very mature senile cataract the effective rate was 80%, all with no side effects.
Another study of lens clarity over a 6 to 24 month period using a 1% solution of NAC eye-drops at 2-drops twice a day into each eye showed at 6-months, 88.9% of all eyes treated with NAC had an improvement of glare sensitivity, 41.5% of all eyes had a significant improvement of the transmissivity of the lens and 90% had improved visual acuity. At 24 months these results were sustained.
Cataract is the result of oxidative stress due in part to oxygen free radicals in the eye and unchecked oxidation results in the cross linking of lens proteins or glycosylation. The result of this cross linking or glycosylation is the discoloration of the eye lens to yellow or brown called lens opacification which limits the amount of light that reaches the retina, resulting in vision impairment. Carnosine can prevent or slow down the process of glycosylation.
L-carnosine is an excellent anti-oxidant and is particularly effective against potent free-radicals and within the aqueous humor region of the eye it slows and prevents the appearance of cataract. But L-carnosine eye-drops alone do not reach the aqueous humor, it is only effective when in NAC which carries the L-Carnosine to where it is needed to work.
NAC eye-drops act as an anti-oxidant in cellular lens membranes and in the aqueous environment and they reduce and protect the lens from the damage caused by oxidative stress-induced glycosylation. This is pertinent to cataract but in another study with younger patients between 48 and 60, who had varying degrees of eyesight impairment but no cataracts, the eye-drops alleviated eye-tiredness and gave clearer vision. The patients described that the treatment had brightened and relaxed their eyes. This is an important indication that NAC eye-drops can be used in the prevention of associated aging vision impairment as well as in medical applications. The drops are a natural lubricant so they are popular with those who wear contact lenses or suffer with dry eye or computer vision syndrome.
NAC eye drops naturally help eyes heal themselves.
If you use contact lenses, remove these before applying NAC Eye Drops. Ideally, you should then wait at least 15 minutes before putting your lenses back in.
Apply 4 drops daily to each affected eye. 2 in the morning and 2 in the evening. 10 minute gap between each drop. Each vial contains approx 80 drops.
Two (5ml) vials per box = 20-30 days usage.
Made in and shipped from the USA.
NAC Eye Drops are US manufactured eye drops and are not related to or associated with the Can-C branded drops which are manufactured outside the USA and distributed from Great Britain.
Wholesale orders available please contact us for prices. service@ANTIAGINGCENTRAL.com
